Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

6.19
Delayed Data
As of 3:59pm ET
 +0.12 / +1.98%
Today’s Change
3.11
Today|||52-Week Range
8.10
+11.13%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close6.07
Today’s open6.09
Day’s range6.01 - 6.23
Volume29,579
Average volume (3 months)70,881
Market cap$154.4M
Dividend yield--
Data as of 3:59pm ET, 09/27/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-18.18%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book18.78

Competitors

 Today’s
change
Today’s
% change
LFVNLifeVantage Corp-0.32-3.00%
CDTXCidara Therapeutics ...+0.37+3.17%
CDXCChromadex Corp+0.03+1.04%
MTPMidatech Pharma PLC-0.01-0.31%
Data as of 3:59pm ET, 09/27/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Search for Jobs